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Introduction
Multiple symmetrical lipomatosis (MSL), also known as 
Madelung’s disease, benign symmetrical lipomatosis, or 
Launois-Bensaude adenolipomatosis, is a rare benign dis-
ease of unknown pathogenesis.1,2
It was mentioned in the literature for the first time by 
Bordie in 1846 and by Madelung in 1888. Ten years later, 65 
more cases were described by Launois-Bensaude, and the 
disease received his name.1,3 
The disease is more commonly observed in white 
males of Mediterranean origin, aged 30 to 60 years, with 
a male:female ratio of 15:1 to 30:1.1,2 Chronic alcoholism 
is associated with over 90% of cases,1 in addition to meta-
bolic abnormalities such as hyperuricemia, hyperlipidemia, 
glucose intolerance, and others such as macrocytic anemia, 
renal tubular acidosis, and polyneuropathy.2,3
It is clinically characterized by the deposition of multi-
ple symmetric masses of unencapsulated adipose tissue in 
the upper chest and neck region, and it is classified into two 
types.3 Type I presents lipomatous masses in the parotid, 
cervical, suprascapular, and deltoid regions, and there may 
be deep involvement. Type II presents diffuse lipomatosis, 
similar in appearance to common obesity; it is most com-
mon morphology in females.4
A case of multiple symmetric lipomatosis type I is de-
scribed, affecting the supraclavicular region, bilaterally. 
Case presentation
A male patient, 47 years old, white, without comorbidi-
ties, alcoholic for 20 years, presented to this unit with a 
complaint of bulging in the bilateral supraclavicular region, 
painless, which had been progressively growing for the past 
five years.
At physical examination, he showed good overall status, 
with bilateral supraclavicular mass of soft consistency, pain-
less, measuring 10 × 6 cm to the left and 12 × 8 cm to the 
right (Fig. 1A). The computed tomography (CT) confirmed 
the presence of a symmetrical supraclavicular mass, whose 
density was compatible with fat (Fig. 1C). The mass was sur-
gically removed, and the anatomopathological analysis of 
the specimen evidenced the presence of lipomatosis (Figs. 
1D, 1E, 1F). To date, the patient has progressed well with-
out recurrence, and outpatient follow-up has been main-
tained (Fig. 1B). 
Discussion
In spite of the uncertain etiology of MSL, its pathogenesis is 
believed to be related to the dysfunction of cyclic AMP in 
adipocytes and levels of catecholamines responsible for lip-
olysis.3 Alcohol also appears to play a role in the adipocyte 
hyperplasia process2 in genetically susceptible individuals 
through the pro-lipogenesis, antilipolytic, and decreased 
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lipid oxidation effects. Other studies have also suggested 
the presence of mitochondrial inheritance through mutation 
of the maternal gene.3,5
The diagnosis is attained by patient history, physical 
examination, biopsy, and laboratory and imaging tests. 
Complementary tests are important to discard differential 
diagnoses such as multiple familial lipomatosis, sarcomas, 
angiolipomas, lipoblastomas, neurofibromatosis, Dercum’s 
syndrome, Hanhart syndrome, polydysplasia syndrome, 
lymphoproliferative disorders, and muscular dystrophies.2,3
CT is considered the imaging examination of choice 
for diagnosis, preoperative staging, and postoperative fol-
low-up, due to the overlap of findings with magnetic reso-
nance imaging and its lower cost.3
The palliative treatment is surgical through lipectomy 
or liposuction, with good results, although recurrences are 
common due to the difficulty of complete tumor excision, as 
they are not encapsulated.2,3 Some studies have described a 
clinical treatment with β2-agonist, in order to increase the 
adrenergic lipolysis and reduce the accumulation of fat, but 
with questionable efficacy.2 Although weight loss and alco-
hol withdrawal appear to have no effect on disease progres-
sion, these measures associated with surgery can decrease 
the recurrence rate,6 as a longitudinal study showed that the 
amount of alcohol consumed is directly associated with 
the onset of the disease.3
The prognosis can be good if treated early; morbidity 
and mortality are more often associated with complications 
of alcoholism than with the fat deposits directly.3 The le-
sions hardly ever become malignant; however, they may 
evolve with compression of the larynx and trachea and de-
velopment of neuropathies.2 
Final comments 
The identification of this rare disease, the appropriate in-
vestigation for the exclusion of differential diagnosis, and 
early surgical approach as observed in the present case, are 
important to prevent future complications.
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Figure 1 A, preoperative period; B, postoperative period; C, cervical computed tomography; D, intraoperative period, right side;  
E, intraoperative period, right side; F, intraoperative period, left side.
